umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Bisphosphonates and mortality: confounding in observational studies?
Umeå universitet, Medicinska fakulteten, Institutionen för samhällsmedicin och rehabilitering, Geriatrik.
Umeå universitet, Medicinska fakulteten, Institutionen för folkhälsa och klinisk medicin, Avdelningen för hållbar hälsa. School of Sport Sciences, UiT Arctic University of Norway, Postboks 1621, 9509, Alta, Norway..
Department of Care Sciences, Malmö University, 20506, Malmö, Sweden..
Division of Clinical geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Plan 7, 14183, Huddinge, Sweden. Research and Development Unit, Stockholm Sjukhem, Mariebergsgatan 22, 11219, Stockholm, Sweden.. (Theme Aging, Karolinska Univeristy Hospital, 14186, Stockholm, Sweden.)
Vise andre og tillknytning
2019 (engelsk)Inngår i: Osteoporosis International, ISSN 0937-941X, E-ISSN 1433-2965, Vol. 30, nr 10, s. 1973-1982Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Summary: Numerous observational studies suggest that bisphosphonates reduce mortality. This study showed that bisphosphonate use is associated with lower mortality within days of treatment, although the association was not significant until the second week. Such an early association is consistent with confounding, although an early treatment effect cannot be ruled out.

Introduction: The purpose of this study was to examine whether confounding explains why numerous observational studies show that bisphosphonate use is associated with lower mortality. To this end, we examined how soon after treatment initiation a lower mortality rate can be observed. We hypothesized that, due to confounding, the association would be observed immediately.

Methods: This was a retrospective cohort study of hip fracture patients discharged from Swedish hospitals between 1 July 2006 and 31 December 2015. The data covered 260,574 hip fracture patients and were obtained from the Swedish Hip Fracture Register and national registers. Of the 260,574 patients, 49,765 met all eligibility criteria and 10,178 were pair matched (bisphosphonate users to controls) using time-dependent propensity scores. The matching variables were age, sex, diagnoses, prescription medications, type of hip fracture, type of surgical procedure, known or suspected dementia, and physical functioning status.

Results: Over a median follow-up of 2.8 years, 2922 of the 10,178 matched patients died. The mortality rate was 7.9 deaths per 100 person-years in bisphosphonate users and 9.4 deaths in controls, which corresponded to a 15% lower mortality rate in bisphosphonate users (hazard ratio 0.85, 95% confidence interval 0.79–0.91). The risk of death was lower in bisphosphonate users from day 6 of treatment, although the association was not significant until the second week.

Conclusion: Bisphosphonate use was associated with lower mortality within days of treatment initiation. This finding is consistent with confounding, although an early treatment effect cannot be ruled out.

sted, utgiver, år, opplag, sider
Springer London, 2019. Vol. 30, nr 10, s. 1973-1982
Emneord [en]
Bisphosphonates, Death, Mortality, Observational study, Osteoporosis
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-162802DOI: 10.1007/s00198-019-05097-1ISI: 000490600300007PubMedID: 31367949OAI: oai:DiVA.org:umu-162802DiVA, id: diva2:1346769
Forskningsfinansiär
Swedish Research Council, 2016-02584Tilgjengelig fra: 2019-08-29 Laget: 2019-08-29 Sist oppdatert: 2019-11-06bibliografisk kontrollert

Open Access i DiVA

fulltext(1206 kB)4 nedlastinger
Filinformasjon
Fil FULLTEXT02.pdfFilstørrelse 1206 kBChecksum SHA-512
2555ac8c62f908c3e2450c66a6f26077f0c5aed5507ef6773530373a5fea2576a64b61cd8de6c414ec815d17ca3f418cbb1784ab51946420991a819460349b1a
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Bergman, JonathanNordström, AnnaNordström, Peter

Søk i DiVA

Av forfatter/redaktør
Bergman, JonathanNordström, AnnaNordström, Peter
Av organisasjonen
I samme tidsskrift
Osteoporosis International

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 57 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 226 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf